Mayuri Shah, a partner with Bain & Company, said, as has been the case for the last two years, procedures like orthopaedics will see more of an impact than others such as cardiac procedures as they are considered to be more deferrable.

Still, Shah said that cardiac procedures overall are "down meaningfully," spurring questions about whether surgeries traditionally viewed as more emergent are going be under pressure this year as well.